Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2025-09
Stage
Series F
Founded
2005
Headcount
25
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences
About
KAHR Medical is a clinical-stage biotechnology company developing novel immune-recruiting therapies that treat cancer by unleashing the synergistic power of the body's innate and adaptive immune responses. The company's proprietary Multifunctional Immuno-Recruitment Protein (MIRP) technology utilizes engineered fusion proteins that bind overexpressed tumor antigens and activate immune effector pathways. Their lead product, DSP107, is a first-in-class bi-specific CD47x4-1BB targeting T-cell engager for the treatment of various cancers, including colorectal cancer and multiple myeloma. KAHR Bio was founded based on technology developed at the University of Pennsylvania and Thomas Jefferson University.
Headcount over time
25 employees (2026-09) · 1 point
Offices
Modi'in-Maccabim-Re'ut, Israel · HQ / main office
Q&A
- What is KAHR Medical's primary focus?
- KAHR Medical is a biopharmaceutical company that develops novel drug platforms based on bi-functional, immunotherapeutic fusion proteins for cancer treatment.
- When was KAHR Medical founded?
- KAHR Medical was founded in September 2005.
- What is KAHR Medical's lead product?
- KAHR Medical's lead product is DSP107, a first-in-class bi-specific CD47x4-1BB targeting T-cell engager for the treatment of various cancers, including colorectal cancer and multiple myeloma.
- How many employees does KAHR Medical have?
- KAHR Medical has 25 employees, falling within the 11-50 employee bucket.
- What was KAHR Medical's most recent funding round?
- Key investors included Flerie AB and Peregrine Ventures.
- Which investors participated in KAHR Medical's D Round in November 2022?
- The D Round in November 2022 included investments from aMoon and BVF Partners.
- Did KAHR Medical receive FDA clearance for clinical trials?
- Yes, in August 2020, KAHR Medical received FDA clearance to begin clinical trials on its immunotherapy drug to battle cancer.
- What was a significant financing event for KAHR Medical in 2021?
- In June 2021, KAHR Medical announced $46.5 million in financing to advance its multifunctional immunotherapeutic pipeline.
- What was the outcome of the Phase 2 study of DSP107 in colorectal cancer?
- In January 2026, KAHR Bio announced strong topline Phase 2 results for DSP107 in combination with anti-PD-L1 therapy in colorectal cancer.
Team · 7
Yaron Pereg
CEO
Adam Foley-Comer
CMO
Ayelet Chajut
CTO
Iris Pecker
VP CMC
Rinat Tabakman
VP Development
Oren Gez
VP Strategy and Corp. Dev.
Tomer Cohen
CFO and CBO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
cancerbiological-therapydrug-deliverydrug-discoverypharmaceuticalsautoimmune-diseaseschronic-patientsbiopharmaceuticalpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | kahrbio.base44.app |
|---|---|
| linkedin.com/company/6724763 | |
| YouTube | youtube.com/channel/UCAHE_coSjQ1j76fTPMuJ0Yg |
Identifiers & details
| Legal name | KAHR Medical Ltd. |
|---|---|
| Founded | 2005-9 |
| Employees (exact) | 25 |
Radar intelligence
Patents
| EPO | 17 |
|---|
Web history (Wayback)
| Domain | kahrbio.base44.app |
|---|
Certificate / subdomain footprint
| Subdomains | 0 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513736249 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2005-09-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 1 |
| Registry events | 1 — charge (1) |
| Registered address | שדרות דם המכבים 28 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-28 | רישום שעבוד |